asco: pembrolizumab plus chemotherapy for advanced triple-negative breast cancer
Published 3 years ago • 104 plays • Length 10:14Download video MP4
Download video MP3
Similar videos
-
4:11
asco 2020: pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast c...
-
5:34
secondary endpoints from a trial of pembrolizumab plus chemotherapy for metastatic tnbc
-
3:58
parp inhibitors plus immunotherapy for advanced triple negative breast cancer
-
12:45
keynote-355: first-line pembrolizumab plus chemotherapy for metastatic triple-negative breast ca...
-
4:45
atezolizumab plus nab-paclitaxel for advanced triple negative breast cancer
-
1:30
keynote-355: hrqol unaffected by the addition of pembrolizumab to chemotherapy for tnbc
-
4:56
asco: pembrolizumab vs. chemotherapy for msi-h metastatic colorectal cancer
-
5:05
pembrolizumab vs single-agent chemotherapy for metastatic triple negative breast cancer
-
3:18
#esmo21 highlights on combination of pembrolizumab plus chemotherapy in mtnbc: the keynote-355 study
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
2:00
pembrolizumab plus chemotherapy show efficacy for tnbc in keynote-355
-
4:54
keynote-522 updates: pembrolizumab plus neoadjuvant chemotherapy in early triple-negative breast...
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
2:00
ladiratuzumab vedotin plus pembrolizumab for advanced tnbc
-
1:03
remaining questions on the use of neoadjuvant pembrolizumab in early tnbc following keynote-522
-
2:53
keynote-407: pembrolizumab plus chemo improves os and pfs in nsclc
-
1:36
dr. hurvitz on pembrolizumab for tnbc
-
2:34
esmo 2021 breast cancer highlights: tulip and keynote-355
-
6:21
pembrolizumab plus trastuzumab and chemotherapy for her2 metastatic gastric or gastroesophageal...